Balancing or Swinging? Genes, ACTA and other Recent Developments in IP
The past thirty days have given those who follow developments in innovation policy quite a bit of material. First, on March 29th, a US district court (SDNY) held that neither isolated genes nor methods of analyzing or comparing genes were patentable subject matter in Association for Molecular Pathology v. US Patent and Trademark Office (USPTO). … Read More.